Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BTAI | BioXcel Therapeutics, Inc. | Chief Financial Officer | $15K | -$7.48K | -33.2% | Sep 17, 2024 |
ATNM | Actinium Pharmaceuticals, Inc. | Director | Dec 28, 2023 | |||
ATOS | ATOSSA THERAPEUTICS, INC. | Director | Jun 27, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|